Showing results (121-130 of 159) with videos related to
Sort By:
Pageof 16
Journal of Drugs in Dermatology : JDD|March 8, 2012
An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-upKristian Reich, Kim A Papp, Christopher E M Griffiths, et al.The British Journal of Dermatology|November 11, 2023
Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3 years of treatment in randomized phase III trialsKenneth B Gordon, Richard G Langley, Richard B Warren, et al.JAMA Dermatology|May 11, 2022
Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results From Phase 2 and Phase 3 Randomized Clinical TrialsKenneth B Gordon, Richard G Langley, Richard B Warren, et al.American Journal of Clinical Dermatology|August 31, 2025
Bimekizumab Complete Clearance of Both Skin and Nail Psoriasis: Comparative Efficacy in Phase III/IIIb StudiesJoseph F Merola, Richard B Warren, Diamant Thaçi, et al.JAMA Dermatology|October 14, 2020
Effect of Risankizumab on Patient-Reported Outcomes in Moderate to Severe Psoriasis: The UltIMMa-1 and UltIMMa-2 Randomized Clinical TrialsMatthias Augustin, Jo Lambert, Carla Zema, et al.Dermatology and Therapy|February 10, 2025
Analysis of Predefined Safety Events Across Spesolimab Trials in Dermatological and Non-Dermatological ConditionsKenneth B Gordon, Yayoi Tada, Milan J Anadkat, et al.Dermatology and Therapy|August 17, 2024
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical TrialsKenneth B Gordon, Andrew Blauvelt, Hervé Bachelez, et al.Journal of the American Academy of Dermatology|October 16, 2013
Research gaps in psoriasis: opportunities for future studiesCaitriona Ryan, Neil J Korman, Joel M Gelfand, et al.Journal of the American Academy of Dermatology|February 18, 2019
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbiditiesCraig A Elmets, Craig L Leonardi, Dawn M R Davis, et al.Journal of the American Academy of Dermatology|February 18, 2019
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologicsAlan Menter, Bruce E Strober, Daniel H Kaplan, et al.Pageof 16